The FDA is aware of the issues arising from labels mentioning GLP-1 but has no future or intended action on the matter, said Kyle Diamantas, then deputy foods commissioner and now acting FDA commissioner, in a March 24 interview with Bloomberg Law
Dr Bex Parkes is a Clinical Psychologist who specialises in working with complex trauma presentations
Titled The Truth About GLP-1s: What Social Media Isnt Telling You, The event explored the growing global conversation surrounding medications such as Ozempic, Wegovy, and other GLP-1 therapies moving beyond social media headlines to discuss the science, realities, risks, benefits, and future implications of these medications
Wang R, et al
Cagrilintide is not for human or animal consumption , not for therapeutic use, and is not intended to diagnose, treat, cure, or prevent any disease or condition
, ,